Brazilian researchers, in partnership with French institutions, have developed a tool that can predict how patients will respond to natalizumab, one of the most commonly used drugs for treating ...
Google’s AI matches dermatologists in melanoma diagnosis England’s health service is piloting an artificial intelligence tool ...